This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: **Innovative Contributions of Tero Pihlajamaa in Genetic Research**
Introduction
Tero Pihlajamaa, a notable inventor based in Oulu, Finland, has made significant strides in the field of genetics with his groundbreaking patent. His work focuses on the detection of altered gene sequences that play a crucial role in various pathological conditions. Understanding these genetic alterations can pave the way for improved diagnostic and therapeutic strategies.
Latest Patents
Pihlajamaa holds a patent titled "Compositions and methods for detecting altered COL1A1 gene sequences." This invention outlines compositions and methods that assist in determining whether a subject has an alteration in genes encoding Type I or Type IX collagen proteins. The patent describes novel intronic sequences from five human genes—COL1A1, COL1A2, COL9A1, COL9A2, and COL9A3. Additionally, it provides methods for identifying pathological conditions linked to these gene alterations, which could include diseases such as osteoporosis, osteoarthritis, and degenerative joint disease.
Career Highlights
Throughout his career, Tero Pihlajamaa has dedicated himself to advancing genetic research and its applications in healthcare. His innovative approaches to detecting genetic predispositions for various diseases have garnered attention within the scientific community. By incorporating advanced molecular techniques, he has contributed valuable insights into the detection and understanding of collagen-related disorders.
Collaborations
Pihlajamaa has actively collaborated with respected peers in his field, including Darwin J. Prockop and Loretta D. Spotila. These collaborations have enriched his research endeavors and broadened the impact of his work in genetic diagnostics and therapeutic development. The synergy between these scientists has led to further advancements in understanding collagen pathologies.
Conclusion
Tero Pihlajamaa stands out as a significant figure in the realm of genetic research with his dedicated efforts and innovative patent. His work contributes not only to academic knowledge but also to practical applications that could save lives and improve health outcomes. As genetic research continues to evolve, Pihlajamaa's work will undoubtedly play a vital role in shaping future diagnostics and therapies for collagen-related conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile